To this end, a homodimeric His6-C9-C9-Cys construct (Fig. 1c-iii) was assembled to assess the immunohistochemical capacity of this construct to detect CEA in human pancreatic cancer specimens. Here, CEACAM5 is linked to pancreatic neoplasm.